The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?

V Mazziotti, F Crescenzo, E Turano… - Journal of …, 2024 - Springer
Tumor necrosis factor (TNF) is a pleiotropic cytokine regulating many physiological and
pathological immune-mediated processes. Specifically, it has been recognized as an …

[HTML][HTML] Changes of Target Essential Trace Elements in Multiple Sclerosis: A Systematic Review and Meta-Analysis

A Stojsavljević, J Jagodić, T Perović, D Manojlović… - Biomedicines, 2024 - mdpi.com
(1) Background: Multiple sclerosis (MS) is a chronic, complex, and demyelinating disease
closely associated with altered levels of trace elements. Although the first studies into the …

Epidemiology of familial multiple sclerosis in Iran: a national registry-based study

Z Salehi, A Almasi-Hashiani, MA Sahraian, F Ashtari… - BMC neurology, 2022 - Springer
Background Admittedly, little is known about the epidemiological signatures of familial
multiple sclerosis (FMS) in different geographical regions of Iran. Objective To determine the …

A deep learning-based approach for unbiased kinematic analysis in CNS injury

MC Ascona, EK Tieu, E Gonzalez-Vega, DJ Liebl… - Experimental …, 2024 - Elsevier
Traumatic spinal cord injury (SCI) is a devastating condition that impacts over 300,000
individuals in the US alone. Depending on the severity of the injury, SCI can lead to varying …

Comparison of OX40 expression in patients with multiple sclerosis and neuromyelitis optica as an approach to diagnosis

M Manian, M Motallebnezhad, R Nedaeinia… - Allergy, Asthma & …, 2023 - Springer
Background Previous studies have shown that CD134 (OX40) co-stimulation is involved in
the pathogenesis of experimental autoimmune encephalomyelitis (EAE) models and the …

[HTML][HTML] Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment

M Terzi, EM Helvacı, S Şen, C Boz… - Archives of …, 2023 - ncbi.nlm.nih.gov
Method: The first generic fingolimod efficacy and safety data of patients followed-up in 29
different clinical multiple sclerosis units in Turkey were analyzed retrospectively. Data …

Multiple Sclerosis: New Insights into Molecular Pathogenesis and Novel Platforms for Disease Treatment

M Dejbakht, M Akhzari, S Jalili, F Faraji… - … : Current Drug Abuse …, 2024 - ingentaconnect.com
Background: Multiple sclerosis (MS), a chronic inflammatory disorder, affects the central
nervous system via myelin degradation. The cause of MS is not fully known, but during …

Immune-metabolic genesis of pathological processes. Research Results in Pharmacology 5 (4): 19–31

AM Zemskov, TA Berezhnova, VA Zemskova… - 2019 - cyberleninka.ru
This article deals with metabolic-immune processes at rest and under stress conditions,
which, in turn, results in the development of immune-dependent and immune-associated …

Determinants of Disability in Progressive Onset Multiple Sclerosis

M Tütüncü, M Tütüncü, S Sabahattin… - Archives of …, 2020 - pmc.ncbi.nlm.nih.gov
Introduction: To describe the clinical and socio-demographic profiles of the patients with the
progressive onset Multiple Sclerosis (MS) and to explore the determinants of disability …

Vestibüler sistem değerlendirmesinde kullanılan nörolojik testlerden tandem duruş testi'nin multipl skleroz ve sağlıklı bireylerde değerlendirilmesi

B Akdağ - 2021 - acikerisim.gelisim.edu.tr
Merkezi sinir sisteminin kronik immün hastalıklarından biri olan Multipl Skleroz (MS), yaşam
boyu sürmek ile beraber birçok fiziksel ve bilişsel ve vestibüler engellere yol açabilmektedir …